If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.60    0.00 (0.00%)
Bid:
10.20
Ask:
11.00
Spread: 0.80 (7.843%)
Market Cap: £14.73m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Total Voting Rights

13 Jun 2024 13:06

RNS Number : 3635S
Ebiquity PLC
13 June 2024
 

 

Ebiquity Plc

("the Company")

 

13 June 2024

 

 

TVR

 

Following the exercise of options on 12 June 2024, over 45,000 ordinary shares which have been satisfied from the Ebiquity plc Employee Benefit Trust ("EBT"), the EBT now holds 3,879,703 issued Ordinary Shares to satisfy certain LTIP awards for the Company's senior management team. The trustee has agreed not to vote the Ordinary Shares held by it. As such 3,879,703 Ordinary Shares are treated as not carrying voting rights. The figure of 136,606,301 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

 

 

Enquiries: 

 

Ebiquity plc

+44 (0) 20 7650 9600

Lorraine Young, Company Secretary

 

 

 

Camarco

 

Ben Woodford

+44 (0) 7990 653 341

Geoffrey Pelham-Lane

+44 (0) 7733 124 226

 

 

Panmure Gordon (Financial Adviser, Nomad and Broker)

+44 (0) 20 7886 2500

Dominic Morley / Dougie McLeod (Corporate Advisory)

 

Mark Murphy / Sam Elder (Corporate Broking)

 

 

About Ebiquity plc

 

Ebiquity plc (LSE AIM: EBQ) is a world leader in media investment analysis. It harnesses the power of data to provide independent, fact-based advice, enabling brand owners to perfect media investment decisions and improve business outcomes. Ebiquity is able to provide independent, unbiased advice and solutions to brands because we have no commercial interest in any part of the media supply chain.

 

We are a data-driven solutions company helping brand owners drive efficiency and effectiveness from their media spend, eliminating wastage and creating value. We provide analysis and solutions through four Service Lines: Media Management, Media Performance, Marketing Effectiveness, and Contract compliance.

 

Ebiquity's clients are served by more than 600 media specialists operating from 18 offices covering 80% of the global advertising market.

 

The Company has the most comprehensive, independent view of today's global media market, analysing US$55bn of media spend from 75 markets annually, including trillions of digital media impressions. Our Contract compliance division, FirmDecisions, audits US$40bn of contract value annually.

 

As a result, more than 70 of the world's top 100 advertisers today choose Ebiquity as a trusted independent media advisor.

 

For further information, please visit: www.ebiquity.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUORURSNUNAAR
Date   Source Headline
4th Jun 20192:25 pmRNSAGM resolutions passed
30th May 20193:20 pmRNSHolding(s) in Company
1st May 20197:00 amRNSTotal Voting Rights
30th Apr 201912:30 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSAnnual Report
18th Apr 20193:05 pmRNSIssue of Shares
12th Apr 201910:45 amRNSCorrection - Issue of Shares
9th Apr 20197:00 amRNSIssue of Shares
2nd Apr 201910:55 amRNSDirector/PDMR Shareholding
1st Apr 20194:40 pmRNSIssue of Shares
27th Mar 201912:25 pmRNSDirector/PDMR Shareholding
25th Mar 20192:30 pmRNSCorrection - Dividend payment schedule
25th Mar 20197:00 amRNSUnaudited Preliminary Results
1st Mar 20192:15 pmRNSTotal Voting Rights
22nd Feb 20193:55 pmRNSIssue of Shares
18th Feb 20197:00 amRNSHolding(s) in Company
12th Feb 20197:00 amRNSPre-close Trading Update
1st Feb 20197:00 amRNSTotal Voting Rights
23rd Jan 20194:50 pmRNSReplacement: Issue of Shares
23rd Jan 20193:25 pmRNSIssue of Shares
14th Jan 20193:35 pmRNSIssue of Shares
3rd Jan 20192:55 pmRNSIssue of Shares
2nd Jan 201911:40 amRNSDirectorate Change
2nd Jan 201911:40 amRNSCompletion of the disposal of the AdIntel division
2nd Jan 20197:00 amRNSTotal Voting Rights
14th Dec 20187:00 amRNSDirectorate Change
5th Dec 20181:45 pmRNSIssue of Shares
22nd Nov 20187:00 amRNSTrading Update
22nd Nov 20187:00 amRNSStatement re CMA final clearance notification
1st Nov 20187:00 amRNSTotal Voting Rights
24th Oct 20182:40 pmRNSIssue of Shares
23rd Oct 20182:05 pmRNSHolding(s) in Company
18th Oct 20184:06 pmRNSIssue of Shares
15th Oct 20187:00 amRNSIssue of Shares
11th Oct 20187:10 amRNSStatement re CMA Provisional Findings
10th Oct 201812:15 pmRNSDirectorate Change
4th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSTotal Voting Rights
27th Sep 20189:10 amRNSIssue of Shares
25th Sep 20187:00 amRNSDirectorate Change
25th Sep 20187:00 amRNSInterim Results
3rd Aug 20188:51 amRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
27th Jul 20188:59 amRNSHolding(s) in Company
27th Jul 20188:55 amRNSHolding(s) in Company
27th Jul 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jul 20187:00 amRNSInterim Trading Update
20th Jul 20185:00 pmRNSHolding(s) in Company
11th Jul 20183:05 pmRNSAward of options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.